CD8A and Alzheimer disease: We have previously shown that AD patients present with a lower frequency of CMV-specific CD8+ T-cells and that CMV-seropositive AD patients show a more pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype than both CMV-seronegative AD patients and CMV-seropositive non-demented (ND) controls (20, 21).